Israel Biological Institute ready to test coronavirus vaccine
The IIBR updated Gantz that it is prepared to begin the human testing phase of trials on October 21 and is waiting for approval from the Health Ministry's Helinski Committee.
An individual dose of the filled SARS-CoV-2 vaccine candidate made by biotech company IDT Biologika in Dessau-Rosslau, Germany. June 24, 2020(photo credit: HARTMUT BOESENER/IDT BIOLOGIKA/HANDOUT VIA REUTERS)ByJERUSALEM POST STAFF
